share_log

Rite Aid (RAD) Stock Tumbles After Cutting Full-Year Guidance

Rite Aid (RAD) Stock Tumbles After Cutting Full-Year Guidance

Rite Aid(RAD)股票在下调全年预期后暴跌
InvestorPlace ·  2022/09/29 10:57

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

InvestorPlace-股票市场新闻、股票建议和交易提示

Source: Michael Gordon / Shutterstock.com
消息来源:迈克尔·戈登/Shutterstock.com

Rite Aid (NYSE:RAD) stock is falling on Thursday after the pharmacy company updated its guidance for the fiscal full year of 2023.

来德爱(纽约证券交易所:Rad)股价周四下跌,此前这家制药公司更新了2023财年的指引。

That new guidance starts with the company expecting a net loss of $520.3 million to $477.3 million for the year. It's also looking for adjusted losses per share between $1.52 and 97 cents. For the record, Wall Street is expecting an adjusted net loss per share of $1.39 for the year.

这一新的指引始于该公司预计今年净亏损5.203亿至4.773亿美元。该公司还预计调整后每股亏损在1.52美元至97美分之间。根据记录,华尔街预计今年调整后的每股净亏损为1.39美元。

Rite Aid also notes that its new Adjusted EBITDA outlook ranges from $450 million to $490 million. That's a drop from its prior guidance of $460 million and $500 million.

Rite Aid还指出,其新的调整后EBITDA预期在4.5亿美元至4.9亿美元之间。这比之前4.6亿美元和5亿美元的指引有所下降。

According to Rite Aid, several factors are behind its new guidance. That includes goodwill impairment charges in the Pharmacy Services Segment. It also cites increased impairment charges from closed stores as another reason for the update.

根据Rite Aid的说法,其新指导背后有几个因素。这包括药房服务部门的商誉减值费用。该公司还指出,关闭门店的减值费用增加是更新的另一个原因。

Adding to that, cautious consumer demand is another reason for its new outlook. Finally, the company notes that continued supply chain problems are also having an effect on its business.

此外,谨慎的消费者需求是其新前景的另一个原因。最后,该公司指出,持续的供应链问题也对其业务产生了影响。

RAD's CEO Addresses the New Guidance

RAD的首席执行官发表了新的指导意见

Heyward Donigan, president and CEO of Rite Aid, said the following about the update.

礼仪援助公司首席执行官兼首席执行官总裁·海沃德·多尼根就此次更新发表了以下看法。

"As we look to the second half of the year, we expect continued pressure on consumer spending and supply chain challenges. At the same time, we are ready to meet a high demand for immunizations, while driving continued strong performance at Elixir and further SG&A expense reductions."

展望今年下半年,我们预计消费者支出和供应链挑战将继续面临压力。与此同时,我们准备满足对疫苗的高需求,同时推动Elixir的持续强劲表现和进一步的SG&A费用削减。

RAD stock is down 28.3% as of Thursday morning.

截至周四上午,Rad股价下跌28.3%。

There's more hot stock market news worth checking out below!

下面有更多值得一看的股市热点新闻!

We've got all of the hottest stock market news traders need to know about for Thursday! A few examples include what has shares of Peloton (NASDAQ:PTON), Porsche Automobil Holding (OTCMKTS:POAHY), and Bed Bath & Beyond (NASDAQ:BBBY) stock in the news today. You can read up on all of that at the following links!

我们有所有交易员周四需要知道的最热门的股市消息!几个例子包括哪些股票佩洛顿*(纳斯达克:PTON),保时捷汽车保时捷G(OTCMKTS:POAHY),以及床浴及更上一层楼*(纳斯达克:BBBY今天的新闻中有股票。你可以在下面的链接上阅读所有这些内容!

More Thursday Stock Market News

更多周四股市新闻

  • PTON Stock Alert: What to Know as Peloton Hits the Shelves at Dick's Sporting Goods
  • Porsche IPO Sends POAHY Stock Into the Spotlight. Here's Why.
  • Bed Bath & Beyond (BBBY) Stock Falls on Q2 Loss
  • PTON库存警报:当Peloton在Dick‘s体育用品上架时要知道什么
  • 保时捷IPO让POAHY股票成为聚光灯下的焦点。这就是为什么。
  • Bed Bath&Beyond股价第二季度下跌

On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.

在出版日期,威廉·怀特他没有(直接或间接)持有本文所述证券的任何头寸。本文表达的观点是作者的观点,以InvestorPlace.com为准。出版指南

The post Rite Aid (RAD) Stock Tumbles After Cutting Full-Year Guidance appeared first on InvestorPlace.

Rite Aid(RAD)的股票在削减全年指引后的震荡最先出现在InvestorPlace上。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发